Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
IL-27: a potential biomarker for responders to glatiramer acetate therapy.
The importance of collecting structured clinical information on multiple sclerosis.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.
Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.
Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2.
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Adherence and persistence to drug therapies for multiple sclerosis: A population-based study.
TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Engineering Biomaterials to Influence Oligodendroglial Growth, Maturation, and Myelin Production.
Progressive Multiple Sclerosis.
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.
Pattern and Outcome of Acute Disseminated Encephalomyelitis (ADEM) in Children: Experience in a Tertiary Center, Upper Egypt.
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia.
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
A genetic basis for multiple sclerosis severity: Red herring or real?
[Influence of manganese exposure via intracerebral injection on behavioristics and substantia nigra dopaminergic neurons in rats].
A Post-stroke Therapeutic Regimen with Omega-3 Polyunsaturated Fatty Acids that Promotes White Matter Integrity and Beneficial Microglial Responses after Cerebral Ischemia.
Developing connections amongst B lymphocytes and deregulated pathways in autoimmunity.
Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia.
Deficits in medio-lateral balance control and the implications for falls in individuals with multiple sclerosis.
Antigen dynamics govern the induction of CD4(+) T cell tolerance during autoimmunity.
Impaired Frontolimbic Connectivity and Depressive Symptoms in Patients with Alzheimer's Disease.
Autophagy Is Involved in the Sevoflurane Anesthesia-Induced Cognitive Dysfunction of Aged Rats.
Pages
« first
‹ previous
…
803
804
805
806
807
808
809
810
811
…
next ›
last »